Annual report pursuant to Section 13 and 15(d)

Revenue Recognition

Revenue Recognition
12 Months Ended
Dec. 31, 2018
Revenue Recognition [Abstract]  
Revenue Recognition

Note 2 - Revenue Recognition


Contracts with Customers


We have adopted ASC 606, Revenue from Contracts with Customers effective January 1, 2018 using the modified retrospective method applied to those contracts which were not substantially completed as of January 1, 2018. These standards provide guidance on recognizing revenue, including a five-step model to determine when revenue recognition is appropriate. The standard requires that an entity recognize revenue to depict the transfer of control of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. Revenues for 2018 are reported under ASC 606, while prior period amounts are not adjusted and continue to be reported under ASC 605, Revenue Recognition.


We routinely plan on entering into contracts with customers that include general commercial terms and conditions, notification requirements for price increases, shipping terms and in most cases prices for the products and services that we offer. Our performance obligations are established when a customer submits a purchase order notification (in writing, electronically or verbally) for goods and services, and we accept the order. We identify performance obligations as the delivery of the requested product or service in appropriate quantities and to the location specified in the customer’s contract and/or purchase order. We generally recognize revenue upon the satisfaction of these criteria when control of the product or service has been transferred to the customer at which time we have an unconditional right to receive payment. Our sales and sale prices are final and our prices are not affected by contingent events that could impact the transaction price.


Revenues for our SofPulse® product is typically recognized at the time the product is shipped, at which time the title passes to the customer, and there are no further performance obligations.


In connection with offering products and services provided to the end user by third-party vendors, we review the relationship between us, the vendor and the end user to assess whether revenue should be reported on a gross or net basis. In asserting whether revenue should be reported on a gross or net basis, we consider whether we act as a principal in the transaction and control the goods and services used to fulfill the performance obligation(s) associated with the transaction.


During the year ended December 31, 2018, we recognized net revenue of $17,045 from products with a selling price of $43,196 and gross revenue of $66,218 from products we sold as a principal in the transaction.


Sources of Revenue


We have identified the following revenues disaggregated by revenue source:


  1. Plastic Surgeons
  2. Wound Care Facilites
  3. Hospitals
  4. Other Physicians


As of December 31, 2018 and 2017 the sources of revenue were as follows:


    Year Ended  
    December 31,  
    2018     2017  
Distributor- Plastic surgeons, net   $ 17,045     $ -  
Direct sales- Plastic surgeons, gross     66,218       -  
Total sources of revenue   $ 83,263     $ -  




Our general product warranties do not extend beyond an assurance that the product delivered will be consistent with stated specifications and do not include separate performance obligations.


Significant Judgments in the Application of the Guidance in ASC 606


There are no significant judgments associated with the satisfaction of our performance obligations. We generally satisfy performance obligations upon delivery of the product to the customer. This is consistent with the time in which the customer obtains control of the products. Performance obligations are also generally settled quickly after the purchase order acceptance, therefore the value of unsatisfied performance obligations at the end of any reporting period is generally immaterial.


We consider variable consideration in establishing the transaction price. Forms of variable consideration applicable to our arrangements include sales returns, rebates, volume-based bonuses, and prompt pay discounts. We use historical information along with an analysis of the expected value to properly calculate and to consider the need to constrain estimates of variable consideration. Such amounts are included as a reduction to revenue from the sale of products in the periods in which the related revenue is recognized and adjusted in future periods as necessary.


Practical Expedients


Our payment terms for sales direct to distributors, End Users, Hospitals and Doctors are substantially less than the one-year collection period that falls within the practical expedient in determination of whether a significant financing component exists.


Taxes Collected from Customers


Taxes collected on the value of transaction revenue are excluded from product revenues and are accrued in current liabilities until remitted to governmental authorities.


Effective Date and Transition Disclosures


Adoption of the new standards related to revenue recognition did not have a material impact on our consolidated financial statements.